Brightside Health 9.1/10
Best for: measurement-based psychiatric care with published outcomesUses a proprietary algorithm plus PHQ-9/GAD-7 symptom tracking to guide SSRI/SNRI prescribing, and publishes its own outcomes data (self-reported: ~72% of patients see symptom improvement by week 12). Psychiatry and therapy offered separately or combined; broad insurance acceptance.
Published, measurement-based outcomes tracking is a meaningfully stronger evidence signal than most competitors offer: see our research library for how this compares to trial-level efficacy data.